For adults with T2D at high risk of major CV events Ozempic (semaglutide) pill: proven CV risk reduction 6 (semaglutide) pill: proven CV risk reduction 6 Start Ozempic pill today in adults with T2D who are at high risk for major CV events Ozempic pill can significantly lower the risk of MACE 6,7 pill can significantly lower the risk of MACE 6,7 Primary composite endpoint: Reduction in risk of MACE with semaglutide tablets 14 mg vs placebo when both were added to SOC in adults with T2D and established CVD and/or CKD 6 Time to first confirmed MACE (CV death, nonfatal MI, or nonfatal stroke) 6,7,b NNT 50 Number needed to treat to prevent d 1 MACE (3 years) 7,d Ozempic tablets 1.5 mg, 4 mg, and 9 mg are an updated formulation with increased bioavailability
Volarevic V, Markovic BS, Gazdic M, et al
Conclusion GLP-1 medications present cost challenges, with monthly expenses often exceeding $1,000 monthly without insurance coverage
For instance, the THADA rs13429458 polymorphism did not exhibit a difference in insulin resistance, while the DENND1A rs2479106GG and AG genotypes were linked to a lower risk of IR in PCOS individuals (Tian et al., 2020
Differences can include which medication is covered, prior authorization requirements, copays, and deductibles
Were typically looking at a timeframe of it happening at least once a week for a few months